Showing results (1181-1190 of 3,473) with videos related to
Sort By:
Pageof 348
Clinical Pharmacokinetics|November 11, 2003
Clinical pharmacokinetics of drugs used to treat urge incontinenceDavid R P GuayClinical Pharmacokinetics|September 10, 2003
Pharmacokinetic and pharmacodynamic differences between two low dosages of aspirin may affect therapeutic outcomesChiara Cerletti, Giuseppe Dell'Elba, Stefano Manarini, et al.Clinical Pharmacokinetics|January 1, 1992
The effect of food on the bioavailability of temafloxacin. A review of 3 studiesG R Granneman, D MukherjeeClinical Pharmacokinetics|August 1, 1992
Pharmacokinetic optimisation of antiemetic therapyM Campbell, D N BatemanClinical Pharmacokinetics|January 13, 2004
Treatment of the metabolic disturbances caused by antipsychotic drugs: focus on potential drug interactionsTrino Baptista, N M K Ng Ying Kin, Serge BeaulieuClinical Pharmacokinetics|October 9, 2003
Macromolecular therapeutics: advantages and prospects with special emphasis on solid tumour targetingKhaled Greish, Jun Fang, Takao Inutsuka, et al.Clinical Pharmacokinetics|October 10, 2007
Mechanism-based pharmacokinetic-pharmacodynamic modelling of the reversal of buprenorphine-induced respiratory depression by naloxone : a study in healthy volunteersAshraf Yassen, Erik Olofsen, Eveline van Dorp, et al.Clinical Pharmacokinetics|November 22, 2007
Population pharmacokinetics and pharmacodynamics of doxorubicin and cyclophosphamide in breast cancer patients: a study by the EORTC-PAMM-NDDGMarkus Joerger, Alwin D R Huitema, Dick J Richel, et al.Clinical Pharmacokinetics|May 1, 1991
Ethnic differences in drug disposition and responsivenessA J Wood, H H ZhouClinical Pharmacokinetics|August 14, 2008
A clinical comparison of slow- and rapid-escalation treprostinil dosing regimens in patients with pulmonary hypertensionNika Skoro-Sajer, Irene M Lang, Evis Harja, et al.Pageof 348